Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 216, Issue -, Pages S801-S804Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jix402
Keywords
human immunodeficiency virus (HIV); drug resistance; monitoring; prevention; response
Categories
Funding
- National Institute of Allergy and Infectious Disease, NIH
- Centers for Disease Control and Prevention
Ask authors/readers for more resources
The global community, including the World Health Organization (WHO), has committed to ending the AIDS epidemic and to ensuring that 90% of people living with human immunodeficiency virus (HIV) are diagnosed, 90% start treatment, and 90% achieve and maintain virological suppression. The emergence of HIV drug resistance (HIVDR) as antiretroviral treatment programs expand could preclude the 90-90-90 targets adopted by the United Nations General Assembly at the High-Level Meeting on Ending AIDS from being achieved. The Global Action Plan on HIVDR is a call for collective action grounded on normative guidance providing a standardized and robust approach to monitoring, preventing, and responding to HIVDR over the next 5 years (2017-2021). WHO is committed to supporting country, global, regional, and national partners to implement and monitor the progress of the Global Action Plan. This article outlines the key components of WHO's strategy to tackle HIVDR and the role the organization takes in leading the global response to HIVDR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available